Streptococcus pneumoniae type 19f capsular polysaccharide antigen

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Brand Names
Pneumovax 23, Prevnar 13, Vaxneuvance
Generic Name
Streptococcus pneumoniae type 19f capsular polysaccharide antigen
DrugBank Accession Number
DB10336
Background

Streptococcus pneumoniae type 19f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 19f of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.

Type
Biotech
Groups
Approved, Investigational
Biologic Classification
Vaccines
Other vaccines
Synonyms
  • pneumococcal capsular polysaccharide type 19F vaccine
  • Pneumococcal polysaccharide serotype 19F

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
ApexxnarStreptococcus pneumoniae type 19f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 1 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 10a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 11a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 12f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 14 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 15b capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 18c capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 19a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 22F capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 23f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 3 capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 33F capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 4 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 5 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 6a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 6b capsular polysaccharide antigen (4.4 µg/0.5ml) + Streptococcus pneumoniae type 7f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 8 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 9v capsular polysaccharide antigen (2.2 µg/0.5ml)Injection, suspensionIntramuscularPfizer Europe Ma Eeig2022-06-06Not applicableEU flag
ApexxnarStreptococcus pneumoniae type 19f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 1 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 10a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 11a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 12f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 14 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 15b capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 18c capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 19a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 22F capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 23f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 3 capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 33F capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 4 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 5 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 6a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 6b capsular polysaccharide antigen (4.4 µg/0.5ml) + Streptococcus pneumoniae type 7f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 8 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 9v capsular polysaccharide antigen (2.2 µg/0.5ml)Injection, suspensionIntramuscularPfizer Europe Ma Eeig2022-06-06Not applicableEU flag
ApexxnarStreptococcus pneumoniae type 19f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 1 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 10a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 11a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 12f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 14 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 15b capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 18c capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 19a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 22F capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 23f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 3 capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 33F capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 4 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 5 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 6a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 6b capsular polysaccharide antigen (4.4 µg/0.5ml) + Streptococcus pneumoniae type 7f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 8 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 9v capsular polysaccharide antigen (2.2 µg/0.5ml)Injection, suspensionIntramuscularPfizer Europe Ma Eeig2022-06-06Not applicableEU flag
ApexxnarStreptococcus pneumoniae type 19f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 1 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 10a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 11a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 12f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 14 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 15b capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 18c capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 19a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 22F capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 23f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 3 capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 33F capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 4 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 5 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 6a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 6b capsular polysaccharide antigen (4.4 µg/0.5ml) + Streptococcus pneumoniae type 7f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 8 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 9v capsular polysaccharide antigen (2.2 µg/0.5ml)Injection, suspensionIntramuscularPfizer Europe Ma Eeig2022-06-06Not applicableEU flag
ApexxnarStreptococcus pneumoniae type 19f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 1 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 10a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 11a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 12f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 14 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 15b capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 18c capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 19a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 22F capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 23f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 3 capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 33F capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 4 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 5 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 6a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 6b capsular polysaccharide antigen (4.4 µg/0.5ml) + Streptococcus pneumoniae type 7f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 8 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 9v capsular polysaccharide antigen (2.2 µg/0.5ml)Injection, suspensionIntramuscularPfizer Europe Ma Eeig2022-06-06Not applicableEU flag
ApexxnarStreptococcus pneumoniae type 19f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 1 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 10a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 11a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 12f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 14 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 15b capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 18c capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 19a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 22F capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 23f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 3 capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 33F capsular polysaccharide diphtheria CRM197 protein conjugate antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 4 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 5 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 6a capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 6b capsular polysaccharide antigen (4.4 µg/0.5ml) + Streptococcus pneumoniae type 7f capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 8 capsular polysaccharide antigen (2.2 µg/0.5ml) + Streptococcus pneumoniae type 9v capsular polysaccharide antigen (2.2 µg/0.5ml)Injection, suspensionIntramuscularPfizer Europe Ma Eeig2022-06-06Not applicableEU flag
PNEUMOVAX ® 23 (VACUNA PNEUMOCOCO POLIVALENTE)Streptococcus pneumoniae type 19f capsular polysaccharide antigen (25 mcg) + Streptococcus pneumoniae type 1 capsular polysaccharide antigen (25 mcg) + Streptococcus pneumoniae type 10a capsular polysaccharide antigen (25 mcg) + Streptococcus pneumoniae type 11a capsular polysaccharide antigen (25 mcg) + Streptococcus pneumoniae type 12f capsular polysaccharide antigen (25 mcg) + Streptococcus pneumoniae type 14 capsular polysaccharide antigen (25 mcg) + Streptococcus pneumoniae type 15b capsular polysaccharide antigen (25 mcg) + Streptococcus pneumoniae type 17f capsular polysaccharide antigen (25 mcg) + Streptococcus pneumoniae type 18c capsular polysaccharide antigen (25 mcg) + Streptococcus pneumoniae type 19a capsular polysaccharide antigen (25 mcg) + Streptococcus pneumoniae type 2 capsular polysaccharide antigen (25 mcg) + Streptococcus pneumoniae type 20 capsular polysaccharide antigen (25 mcg) + Streptococcus pneumoniae type 22f capsular polysaccharide antigen (25 mcg) + Streptococcus pneumoniae type 23f capsular polysaccharide antigen (25 mcg) + Streptococcus pneumoniae type 3 capsular polysaccharide antigen (25 mcg) + Streptococcus pneumoniae type 33f capsular polysaccharide antigen (25 mcg) + Streptococcus pneumoniae type 4 capsular polysaccharide antigen (25 mcg) + Streptococcus pneumoniae type 5 capsular polysaccharide antigen (25 mcg) + Streptococcus pneumoniae type 6b capsular polysaccharide antigen (25 mcg) + Streptococcus pneumoniae type 7f capsular polysaccharide antigen (25 mcg) + Streptococcus pneumoniae type 8 capsular polysaccharide antigen (25 mcg) + Streptococcus pneumoniae type 9n capsular polysaccharide antigen (25 mcg) + Streptococcus pneumoniae type 9v capsular polysaccharide antigen (25 mcg)SolutionIntramuscular; SubcutaneousMERCK SHARP & DOHME COLOMBIA S.A.S2008-01-23Not applicableColombia flag
Pneumovax 23Streptococcus pneumoniae type 19f capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 1 capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 10a capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 11a capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 12f capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 14 capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 15b capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 17f capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 18c capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 19a capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 2 capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 20 capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 22f capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 23f capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 3 capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 33f capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 4 capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 5 capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 6b capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 7f capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 8 capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 9n capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 9v capsular polysaccharide antigen (25 ug/0.5mL)Injection, solutionIntramuscular; SubcutaneousMerck Sharp & Dohme Llc1983-07-072015-05-16US flag
Pneumovax 23Streptococcus pneumoniae type 19f capsular polysaccharide antigen (25 mcg/0.5mL) + Streptococcus pneumoniae type 1 capsular polysaccharide antigen (25 mcg/0.5mL) + Streptococcus pneumoniae type 10a capsular polysaccharide antigen (25 mcg/0.5mL) + Streptococcus pneumoniae type 11a capsular polysaccharide antigen (25 mcg/0.5mL) + Streptococcus pneumoniae type 12f capsular polysaccharide antigen (25 mcg/0.5mL) + Streptococcus pneumoniae type 14 capsular polysaccharide antigen (25 mcg/0.5mL) + Streptococcus pneumoniae type 15b capsular polysaccharide antigen (25 mcg/0.5mL) + Streptococcus pneumoniae type 17f capsular polysaccharide antigen (25 mcg/0.5mL) + Streptococcus pneumoniae type 18c capsular polysaccharide antigen (25 mcg/0.5mL) + Streptococcus pneumoniae type 19a capsular polysaccharide antigen (25 mcg/0.5mL) + Streptococcus pneumoniae type 2 capsular polysaccharide antigen (25 mcg/0.5mL) + Streptococcus pneumoniae type 20 capsular polysaccharide antigen (25 mcg/0.5mL) + Streptococcus pneumoniae type 22f capsular polysaccharide antigen (25 mcg/0.5mL) + Streptococcus pneumoniae type 23f capsular polysaccharide antigen (25 mcg/0.5mL) + Streptococcus pneumoniae type 3 capsular polysaccharide antigen (25 mcg/0.5mL) + Streptococcus pneumoniae type 33f capsular polysaccharide antigen (25 mcg/0.5mL) + Streptococcus pneumoniae type 4 capsular polysaccharide antigen (25 mcg/0.5mL) + Streptococcus pneumoniae type 5 capsular polysaccharide antigen (25 mcg/0.5mL) + Streptococcus pneumoniae type 6b capsular polysaccharide antigen (25 mcg/0.5mL) + Streptococcus pneumoniae type 7f capsular polysaccharide antigen (25 mcg/0.5mL) + Streptococcus pneumoniae type 8 capsular polysaccharide antigen (25 mcg/0.5mL) + Streptococcus pneumoniae type 9n capsular polysaccharide antigen (25 mcg/0.5mL) + Streptococcus pneumoniae type 9v capsular polysaccharide antigen (25 mcg/0.5mL)SolutionIntramuscular; SubcutaneousMerck Ltd.2021-04-07Not applicableCanada flag
Pneumovax 23Streptococcus pneumoniae type 19f capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 1 capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 10a capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 11a capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 12f capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 14 capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 15b capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 17f capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 18c capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 19a capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 2 capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 20 capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 22f capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 23f capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 3 capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 33f capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 4 capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 5 capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 6b capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 7f capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 8 capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 9n capsular polysaccharide antigen (25 ug/0.5mL) + Streptococcus pneumoniae type 9v capsular polysaccharide antigen (25 ug/0.5mL)Injection, solutionIntramuscular; SubcutaneousPhysicians Total Care, Inc.1994-09-202009-06-30US flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
5K0VU709JD
CAS number
Not Available

References

General References
Not Available
PubChem Substance
347910515
RxNav
854948

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4Active Not RecruitingPreventionDiphtheria1
4Active Not RecruitingPreventionInvasive Pneumococcal Disease, Protection Against / Pneumococcal Infection / Streptococcus Pneumoniae Infections1
4Active Not RecruitingPreventionPlasma Cell Neoplasms1
4Active Not RecruitingPreventionPneumococcal Infection1
4CompletedBasic ScienceAging / Pneumonia1
4CompletedDiagnosticCrohn's Disease (CD)1
4CompletedDiagnosticImmune Responses / Pneumonia / Streptococcus Pneumoniae1
4CompletedPreventionAcute Lymphoblastic Leukemia (ALL)1
4CompletedPreventionAsthma2
4CompletedPreventionBCG Infection / Immune Responses / Vaccine Reaction1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solutionIntramuscular; Subcutaneous
SolutionIntramuscular; Subcutaneous
Injection, solutionSubcutaneous
Injection, suspensionIntramuscular32 mcg
SuspensionIntramuscular
InjectionIntramuscular
Injection, suspensionIntramuscular
Injection
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at December 01, 2015 20:03 / Updated at June 12, 2020 16:53